Critical Care Diagnostics Market

Future Market Insights

Key Insight

The critical care diagnostics market is projected to grow from USD 1.4 billion in 2025 to USD 2.3 billion by 2035, at a CAGR of 5.1%. Glucose Monitoring Kits will dominate with a 18.5% market share, while prescription-based testing kits will lead the prescription mode segment with a 55.3% share.

September 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Critical Care Diagnostics Market

https://www.futuremarketinsights.com/reports/critical-care-diagnostics-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Alere Inc
Bayer Healthcare LLC
Beckman Coulter
Becton
Bio-Rad Laboratories
BioMerieux SA
Biosensors Japan Co. Ltd
Chembio Diagnostic Systems
Dickinson
EKF Diagnostics
Nanomix Inc
Nova Biomedical
Roche Diagnostics (Schweiz) AG
Siemens
Sysmex Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Critical Care Diagnostics Market

Key Players

Similar Industry Reports